AbbVie (ABBV) Payables (2016 - 2025)
Historic Payables for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $37.4 billion.
- AbbVie's Payables rose 2268.46% to $37.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $37.4 billion, marking a year-over-year increase of 2268.46%. This contributed to the annual value of $31.9 billion for FY2024, which is 422.51% up from last year.
- Per AbbVie's latest filing, its Payables stood at $37.4 billion for Q3 2025, which was up 2268.46% from $34.2 billion recorded in Q2 2025.
- AbbVie's 5-year Payables high stood at $37.4 billion for Q3 2025, and its period low was $20.6 billion during Q1 2021.
- For the 5-year period, AbbVie's Payables averaged around $27.3 billion, with its median value being $27.0 billion (2023).
- Its Payables has fluctuated over the past 5 years, first surged by 6211.56% in 2021, then surged by 280.51% in 2024.
- Over the past 5 years, AbbVie's Payables (Quarter) stood at $22.7 billion in 2021, then increased by 11.84% to $25.4 billion in 2022, then increased by 20.66% to $30.6 billion in 2023, then grew by 4.23% to $31.9 billion in 2024, then increased by 17.1% to $37.4 billion in 2025.
- Its Payables was $37.4 billion in Q3 2025, compared to $34.2 billion in Q2 2025 and $32.6 billion in Q1 2025.